In mouse xenotransplantation models, SIRT7 knockdown inhibits tumor growth and enhances the antitumor effects of TMZ, suggesting that targeting sirtuin 7 could be a promising therapeutic strategy to improve chemotherapy efficacy in glioma patients [147]. The gene discussed is SIRT7; the disease is central nervous system cancer.